Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Service (Clinical Monitoring, Data Management), By End-use, By Region, And Segment Forecasts, 2022 - 2030

Table of Content

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation & Scope
                       1.1.1 Type
                       1.1.2 Service
                       1.1.3 Regional scope
                       1.1.4 Estimates and forecast timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database
                       1.3.2 Gvr’s Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details Of Primary Research
                   1.4 Information or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis (Model 1)
                       1.6.2 Volume Price Analysis (Model 2)
                   1.7 List of Secondary Sources
                   1.8 List of Primary Sources
                   1.9 List of Abbreviations
                   1.10 Objectives
                       1.10.1 Objective - 1: Understanding the market dynamics
                       1.10.2 Objective - 2: Understanding the market estimates and forecasts
                       1.10.3 Objective - 3: Understanding the attributes such as strategy framework
                       1.10.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size
Chapter 2 Executive Summary
                   2.1 Market Outlook
Chapter 3 Healthcare CRO Market: Variables, Trends, & Scope
                   3.1 Market Segmentation and Scope
                   3.2 Market Driver Analysis
                       3.2.1 Increasing adoption of advanced technologies
                       3.2.2 Increasing mergers and collaborations
                       3.2.3 Increasing outsourcing of R&D activities
                       3.2.4 Patent cliff
                       3.2.5 Favorable environment for clinical trials in developing countries
                   3.3 Market Restraint Analysis
                       3.3.1 Quality issues of CRO services
                       3.3.2 Intellectual property rights issues
                   3.4 Penetration & Growth Prospect Mapping
                   3.5 Porter’s Five Forces Analysis
                   3.6 PESTEL Analysis
Chapter 4 Healthcare CRO Market: Stage Segment Analysis
                   4.1 Healthcare CRO: Market Share Analysis, 2021 & 2030
                   4.2 Drug Discovery
                       4.2.1 Drug Discovery market, 2018 - 2030 (USD Million)
                       4.2.2 Target validation
                           4.2.2.1 Target validation market, 2018 - 2030 (USD Million)
                       4.2.3 Lead identification
                           4.2.3.1 Lead identification market, 2018 - 2030 (USD Million)
                       4.2.4 Lead optimization
                           4.2.4.1 Lead optimization market, 2018 - 2030 (USD Million)
                   4.3 Pre-Clinical
                       4.3.1 Pre-Clinical market, 2018 - 2030 (USD Million)
                   4.4 Clinical
                       4.4.1 Clinical market, 2018 - 2030 (USD Million)
                       4.4.2 Phase I Trial Services
                           4.4.2.1 Phase I trial services market, 2018 - 2030 (USD Million)
                       4.4.3 Phase II Trial Services
                           4.4.3.1 Phase II trial services market, 2018 - 2030 (USD Million)
                       4.4.4 Phase III Trial Services
                           4.4.4.1 Phase III trial services market, 2018 - 2030 (USD Million)
                       4.4.5 Phase IV Trial Services
                           4.4.5.1 Phase IV trial services market, 2018 - 2030 (USD Million)
Chapter 5 Healthcare CRO Market: Service Segment Analysis
                   5.1 Healthcare CRO: Market Share Analysis, 2021 & 2030
                   5.2 Project Management/Clinical Supply Management
                       5.2.1 Project Management/Clinical Supply Management market, 2018 - 2030 (USD Million)
                   5.3 Data Management
                       5.3.1 Data Management market, 2018 - 2030 (USD Million)
                   5.4 Regulatory/Medical Affairs
                       5.4.1 Regulatory/Medical Affairs market, 2018 - 2030 (USD Million)
                   5.5 Medical Writing
                       5.5.1 Medical Writing market, 2018 - 2030 (USD Million)
                   5.6 Clinical Monitoring
                       5.6.1 Clinical Monitoring market, 2018 - 2030 (USD Million)
                   5.7 Quality Management/ Assurance
                       5.7.1 Quality Management/ Assurance market, 2018 - 2030 (USD Million)
                   5.8 Bio-statistics
                       5.8.1 Bio-statistics market, 2018 - 2030 (USD Million)
                   5.9 Investigator Payments
                       5.9.1 Investigator Payments market, 2018 - 2030 (USD Million)
                   5.10 Laboratory
                       5.10.1 Laboratory market, 2018 - 2030 (USD Million)
                   5.11 Patient and Site Recruitment
                       5.11.1 Patient and site Recruitment market, 2018 - 2030 (USD Million)
                   5.12 Technology Services
                       5.12.1 Technology services market, 2018 - 2030 (USD Million)
                   5.13 Other Services
                       5.13.1 Other services market, 2018 - 2030 (USD Million)
Chapter 6 Healthcare CRO Market: Application Segment Analysis
                   6.1 Healthcare CRO: Market Share Analysis, 2021 & 2030
                   6.2 Oncology
                       6.2.1 Oncology market, 2018 - 2030 (USD Million)
                   6.3 Cardiovascular
                       6.3.1 Cardiovascular market, 2018 - 2030 (USD Million)
                   6.4 Autoimmune/Inflammation
                       6.4.1 Autoimmune/Inflammation market, 2018 - 2030 (USD Million)
                   6.5 Central nervous system (CNS)
                       6.5.1 Central nervous system (CNS) market, 2018 - 2030 (USD Million)
                   6.6 Dermatology
                       6.6.1 Dermatology market, 2018 - 2030 (USD Million)
                   6.7 Infectious diseases
                       6.7.1 Infectious diseases market, 2018 - 2030 (USD Million)
                   6.8 Diabetes
                       6.8.1 Diabetes market, 2018 - 2030 (USD Million)
                   6.9 Pain
                       6.9.1 Pain market, 2018 - 2030 (USD Million)
                   6.10 Others
                       6.10.1 Others market, 2018 - 2030 (USD Million)
Chapter 7 Healthcare CRO Market: End use Segment Analysis
                   7.1 Healthcare CRO: Market Share Analysis, 2021 & 2030
                   7.2 Pharmaceutical & Biopharmaceutical Companies
                       7.2.1 Pharmaceutical & Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
                   7.3 Medical Device Companies
                       7.3.1 Medical Device Companies market, 2018 - 2030 (USD Million)
                   7.4 Others
                       7.4.1 Others market, 2018 - 2030 (USD Million)
Chapter 8 Healthcare CRO Market: Service Segment Analysis
                   8.1 Healthcare CRO: Market Share Analysis, 2021 & 2030
                   8.2 North America
                       8.2.1 North America Healthcare CRO market, 2018 - 2030 (USD Million)
                       8.2.2 U.S.
                           8.2.2.1 U.S. healthcare CRO market, 2018 - 2030 (USD Million)
                       8.2.3 Canada
                           8.2.3.1 Canada healthcare CRO market, 2018 - 2030 (USD Million)
                   8.3 Europe
                       8.3.1 Europe Healthcare CRO market, 2018 - 2030 (USD Million)
                       8.3.2 UK
                           8.3.2.1 UK healthcare CRO market, 2018 - 2030 (USD Million)
                       8.3.3 Germany
                           8.3.3.1 Germany healthcare CRO market, 2018 - 2030 (USD Million)
                       8.3.4 France
                           8.3.4.1 France healthcare CRO market, 2018 - 2030 (USD Million)
                       8.3.5 Italy
                           8.3.5.1 Italy healthcare CRO market, 2018 - 2030 (USD Million)
                       8.3.6 Spain
                           8.3.6.1 Spain healthcare CRO market, 2018 - 2030 (USD Million)
                       8.3.7 Switzerland
                           8.3.7.1 Switzerland healthcare CRO market, 2018 - 2030 (USD Million)
                       8.3.8 Belgium
                           8.3.8.1 Belgium healthcare CRO market, 2018 - 2030 (USD Million)
                       8.3.9 Netherlands
                           8.3.9.1 Netherlands healthcare CRO market, 2018 - 2030 (USD Million)
                       8.3.10 Austria
                           8.3.10.1 Austria healthcare CRO market, 2018 - 2030 (USD Million)
                   8.4 Asia Pacific
                       8.4.1 Asia Pacific Healthcare CRO market, 2018 - 2030 (USD Million)
                       8.4.2 India
                           8.4.2.1 India healthcare CRO market, 2018 - 2030 (USD Million)
                       8.4.3 China
                           8.4.3.1 China healthcare CRO market, 2018 - 2030 (USD Million)
                       8.4.4 Japan
                           8.4.4.1 Japan healthcare CRO market, 2018 - 2030 (USD Million)
                       8.4.5 Korea
                           8.4.5.1 Korea healthcare CRO market, 2018 - 2030 (USD Million)
                       8.4.6 Taiwan
                           8.4.6.1 Taiwan healthcare CRO market, 2018 - 2030 (USD Million)
                       8.4.7 Australia
                           8.4.7.1 Australia healthcare CRO market, 2018 - 2030 (USD Million)
                       8.4.8 Indonesia
                           8.4.8.1 Indonesia healthcare CRO market, 2018 - 2030 (USD Million)
                       8.4.9 Malaysia
                           8.4.9.1 Malaysia healthcare CRO market, 2018 - 2030 (USD Million)
                       8.4.10 Singapore
                           8.4.10.1 Singapore healthcare CRO market, 2018 - 2030 (USD Million)
                       8.4.11 Thailand
                           8.4.11.1 Thailand healthcare CRO market, 2018 - 2030 (USD Million)
                   8.5 Latin America
                       8.5.1 Latin America healthcare CRO market, 2018 - 2030 (USD Million)
                       8.5.2 Brazil
                           8.5.2.1 Brazil healthcare CRO market, 2018 - 2030 (USD Million)
                       8.5.3 Mexico
                           8.5.3.1 Mexico healthcare CRO market, 2018 - 2030 (USD Million)
                       8.5.4 Argentina
                           8.5.4.1 Argentina healthcare CRO market, 2018 - 2030 (USD Million)
                       8.5.5 Colombia
                           8.5.5.1 Colombia healthcare CRO market, 2018 - 2030 (USD Million)
                       8.5.6 Chile
                           8.5.6.1 Chile healthcare CRO market, 2018 - 2030 (USD Million)
                   8.6 MEA
                       8.6.1 MEA healthcare CRO market, 2018 - 2030 (USD Million)
                       8.6.2 South Africa
                           8.6.2.1 South Africa healthcare CRO market, 2018 - 2030 (USD Million)
                       8.6.3 Saudi Arabia
                           8.6.3.1 Saudi Arabia healthcare CRO market, 2018 - 2030 (USD Million)
                       8.6.4 UAE
                           8.6.4.1 UAE healthcare CRO market, 2018 - 2030 (USD Million)
                       8.6.5 Iran
                           8.6.5.1 Iran healthcare CRO market, 2018 - 2030 (USD Million)
                       8.6.6 Israel
                           8.6.6.1 Israel healthcare CRO market, 2018 - 2030 (USD Million)
Chapter 9 Company Profiles
                   9.1 IQVIA HOLDINGS INC.
                       9.1.1 Company overview
                       9.1.2 Financial performance
                       9.1.3 Service benchmarking
                       9.1.4 Strategic initiatives
                   9.2 Covance Inc.
                       9.2.1 Company overview
                       9.2.2 Financial performance
                       9.2.3 Service benchmarking
                       9.2.4 strategic initiatives
                   9.3 Thermo Fisher Scientific
                       9.3.1 Company overview
                       9.3.2 Service benchmarking
                       9.3.3 Strategic initiatives
                   9.4 PAREXEL INTERNATIONAL CORPORATION
                       9.4.1 Company overview
                       9.4.2 Financial performance
                       9.4.3 Servcie benchmarking
                       9.4.4 Strategic initiatives
                   9.5 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
                       9.5.1 Company overview
                       9.5.2 Financial performance
                       9.5.3 Service benchmarking
                       9.5.4 Strategic initiatives
                   9.6 ICON, plc
                       9.6.1 Company overview
                       9.6.2 Financial performance
                       9.6.3 Service benchmarking
                       9.6.4 Strategic initiatives
                   9.7 Medidata Solutions, Inc.
                       9.7.1 Company overview
                       9.7.2 Financial performance
                       9.7.3 Service benchmarking
                       9.7.4 Strategic initiatives
                   9.8 Syneos Health
                       9.8.1 Company overview
                       9.8.2 Financial performance
                       9.8.3 Service benchmarking
                       9.8.4 Strategic initiatives
                   9.9 Pharmaron
                       9.9.1 Company overview
                       9.9.2 Service benchmarking
                       9.9.3 Strategic initiatives
                   9.10 GVK Biosciences Private Limited
                       9.10.1 Company overview
                       9.10.2 Service benchmarking
                       9.10.3 Strategic initiatives
                   9.11 SGS SA
                       9.11.1 Company overview
                       9.11.2 Financial performance
                       9.11.3 Service benchmarking
                       9.11.4 Strategic initiatives
                   9.12 KCR S.A.
                       9.12.1 Company overview
                       9.12.2 Financial performance
                       9.12.3 Service benchmarking
                       9.12.4 strategic initiatives
                   9.13 CTI Clinical Trial & Consulting
                       9.13.1 Company overview
                       9.13.2 Service benchmarking
                       9.13.3 Strategic initiatives
                   9.14 PSI CRO AG
                       9.14.1 Company overview
                       9.14.2 Financial performance
                       9.14.3 Servcie benchmarking
                       9.14.4 Strategic initiatives
                   9.15 Clintec
                       9.15.1 Company overview
                       9.15.2 Financial performance
                       9.15.3 Service benchmarking
                       9.15.4 Strategic initiatives
                   9.16 Worldwide Clinical Trials
                       9.16.1 Company overview
                       9.16.2 Financial performance
                       9.16.3 Service benchmarking
                       9.16.4 Strategic initiatives
                   9.17 Wuxi AppTec
                       9.17.1 Company overview
                       9.17.2 Financial performance
                       9.17.3 Service benchmarking
                       9.17.4 Strategic initiatives
                   9.18 Advanced Clinical
                       9.18.1 Company overview
                       9.18.2 Financial performance
                       9.18.3 Service benchmarking
                       9.18.4 Strategic initiatives
                   9.19 Pharm-Olam, LLC
                       9.19.1 Company overview
                       9.19.2 Service benchmarking
                       9.19.3 Strategic initiatives
                   9.20 Clinipace
                       9.20.1 Company overview
                       9.20.2 Service benchmarking
                       9.20.3 Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 Volume Price Analysis
Fig. 10 Healthcare CRO market snapshot (2019)
Fig. 11 Market trends and outlook
Fig. 12 Healthcare CRO market segmentation
Fig. 13 Market driver relevance analysis (Current & future impact)
Fig. 14 Benefits of using robotic labs
Fig. 15 Pharmaceutical R&D spending 2007-2012 (USD Billion)
Fig. 16 Market restraint relevance analysis (Current & future impact)
Fig. 17 Penetration & growth prospect mapping
Fig. 18 Porter’s five forces analysis
Fig. 19 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 20 Healthcare CRO market stage outlook: Segment dashboard
Fig. 21 Healthcare CRO market: Type movement analysis
Fig. 22 Drug discovery market, 2018 - 2030 (USD Million)
Fig. 23 Target validation market, 2018 - 2030 (USD Million)
Fig. 24 Lead identification market, 2018 - 2030 (USD Million)
Fig. 25 Lead optimization market, 2018 - 2030 (USD Million)
Fig. 26 Pre-clinical market, 2018 - 2030 (USD Million)
Fig. 27 Clinical market, 2018 - 2030 (USD Million)
Fig. 28 Phase I trial services market, 2018 - 2030 (USD Million)
Fig. 29 Phase II trial services market, 2018 - 2030 (USD Million)
Fig. 30 Phase III trial services market, 2018 - 2030 (USD Million)
Fig. 31 Phase IV trial services market, 2018 - 2030 (USD Million)
Fig. 32 Healthcare CRO market service outlook: Segment dashboard
Fig. 33 Healthcare CRO market: Service movement analysis
Fig. 34 Parameters for measuring success of provider solution
Fig. 35 Project management/clinical supply management market, 2018 - 2030 (USD Million)
Fig. 36 Clinical data management flow
Fig. 37 Data management market, 2018 - 2030 (USD Million)
Fig. 38 Regulatory/medical affairs market, 2018 - 2030 (USD Million)
Fig. 39 Medical writing market, 2018 - 2030 (USD Million)
Fig. 40 Clinical monitoring market, 2018 - 2030 (USD Million)
Fig. 41 Quality management/ assurance market, 2018 - 2030 (USD Million)
Fig. 42 Bio-statistics market, 2018 - 2030 (USD Million)
Fig. 43 Investigator payments market, 2018 - 2030 (USD Million)
Fig. 44 Laboratory market, 2018 - 2030 (USD Million)
Fig. 45 Strategic initiatives with positive impact on patient recruitment
Fig. 46 Patient and site recruitment market, 2018 - 2030 (USD Million)
Fig. 47 Technology services market, 2018 - 2030 (USD Million)
Fig. 48 Other services market, 2018 - 2030 (USD Million)
Fig. 49 Healthcare CRO market stage outlook: Application Segment dashboard
Fig. 50 Healthcare CRO market: Application movement analysis
Fig. 51 Oncology market, 2018 - 2030 (USD Million)
Fig. 52 Cardiovascular market, 2018 - 2030 (USD Million)
Fig. 53 Autoimmune/Inflammation market, 2018 - 2030 (USD Million)
Fig. 57 Central nervous system (CNS) market, 2018 - 2030 (USD Million)
Fig. 55 Dermatology market, 2018 - 2030 (USD Million)
Fig. 56 Infectious diseases market, 2018 - 2030 (USD Million)
Fig. 57 Diabetes market, 2018 - 2030 (USD Million)
Fig. 58 Pain market, 2018 - 2030 (USD Million)
Fig. 59 Others market, 2018 - 2030 (USD Million)
Fig. 60 Healthcare CRO market stage outlook: End use Segment dashboard
Fig. 61 Healthcare CRO market: End use movement analysis
Fig. 62 Pharmaceutical & Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
Fig. 63 Medical Device Companies market, 2018 - 2030 (USD Million)
Fig. 64 Others market, 2018 - 2030 (USD Million)
Fig. 65 Regional market: Key takeaways
Fig. 66 Regional outlook, 2020 & 2028
Fig. 67 North America market, 2018 - 2030 (USD Million)
Fig. 68 U.S. market, 2018 - 2030 (USD Million)
Fig. 69 Canada market, 2018 - 2030 (USD Million)
Fig. 70 Europe market, 2018 - 2030 (USD Million)
Fig. 71 U.K. market, 2018 - 2030 (USD Million)
Fig. 72 Germany market, 2018 - 2030 (USD Million)
Fig. 73 France market, 2018 - 2030 (USD Million)
Fig. 74 Italy market, 2018 - 2030 (USD Million)
Fig. 75 Spain market, 2018 - 2030 (USD Million)
Fig. 76 Switzerland market, 2018 - 2030 (USD Million)
Fig. 77 Belgium market, 2018 - 2030 (USD Million)
Fig. 78 Netherlands market, 2018 - 2030 (USD Million)
Fig. 79 Austria market, 2018 - 2030 (USD Million)
Fig. 80 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 81 India market, 2018 - 2030 (USD Million)
Fig. 82 China market, 2018 - 2030 (USD Million)
Fig. 83 Japan market, 2018 - 2030 (USD Million)
Fig. 84 Korea market, 2018 - 2030 (USD Million)
Fig. 85 Taiwan market, 2018 - 2030 (USD Million)
Fig. 86 Australia market, 2018 - 2030 (USD Million)
Fig. 87 Indonesia market, 2018 - 2030 (USD Million)
Fig. 88 Malaysia market, 2018 - 2030 (USD Million)
Fig. 89 Singapore market, 2018 - 2030 (USD Million)
Fig. 90 Thailand market, 2018 - 2030 (USD Million)
Fig. 91 Latin America market, 2018 - 2030 (USD Million)
Fig. 92 Brazil market, 2018 - 2030 (USD Million)
Fig. 93 Mexico market, 2018 - 2030 (USD Million)
Fig. 94 Argentina market, 2018 - 2030 (USD Million)
Fig. 95 Colombia market, 2018 - 2030 (USD Million)
Fig. 96 Chile market, 2018 - 2030 (USD Million)
Fig. 97 MEA market, 2018 - 2030 (USD Million)
Fig. 98 South Africa market, 2018 - 2030 (USD Million)
Fig. 99 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 100 UAE market, 2018 - 2030 (USD Million)
Fig. 101 Iran market, 2018 - 2030 (USD Million)
Fig. 102 Israel market, 2018 - 2030 (USD Million)